BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6432285)

  • 1. [Long-term effect of gliclazide on platelet function in diabetes].
    Pan CY
    Zhonghua Yi Xue Za Zhi; 1984 Apr; 64(4):233-5. PubMed ID: 6432285
    [No Abstract]   [Full Text] [Related]  

  • 2. [Efficacy of gliclazide in short and long-term therapy of older persons with noninsulin-dependent diabetes].
    Djurić DS; Djordjević PB; Micić D; Dragasević M
    Srp Arh Celok Lek; 1981 Nov; 109(11):1503-9. PubMed ID: 7051354
    [No Abstract]   [Full Text] [Related]  

  • 3. Long term improvement in insulin response with gliclazide treatment.
    Bodansky HJ; Medback S; Cudworth AG; Rees LH; de Silva RS
    Diabete Metab; 1982 Dec; 8(4):319-22. PubMed ID: 6761187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of gliclazide on platelet function in patients with diabetes mellitus.
    Violi F; De Mattia GC; Alessandri C; Perrone A; Vezza E
    Curr Med Res Opin; 1982; 8(3):200-3. PubMed ID: 7128193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of the effects of some sulphonylureas on platelet function.
    King JB; Kalk WJ; Vinik AI; Jackson WP; Bracher M; Jacobs P
    S Afr Med J; 1977 Jan; 51(5):124-6. PubMed ID: 322325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the sulphonylurea drugs gliclazide and glibenclamide on blood glucose control and platelet function.
    Klaff LJ; Vinik AI; Jackson WP; Malan E; Kernoff L; Jacobs P
    S Afr Med J; 1979 Aug; 56(7):247-50. PubMed ID: 121645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacodynamics of second generation sulfonylureas: dose-effect curve of gliclazide in type 2 diabetes mellitus].
    Procacci V; Giovine A; Roberto MG; Di Reda N; Lasorsa G; Vendemiale G; Stufano N; Altomare E
    Boll Soc Ital Biol Sper; 1988 Sep; 64(9):817-24. PubMed ID: 3072977
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of diet and gliclazide on the haemostatic system of non-insulin-dependent diabetics.
    Paton RC; Kernoff PB; Wales JK; McNicol GP
    Br Med J (Clin Res Ed); 1981 Oct; 283(6298):1018-20. PubMed ID: 6794745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of gliclazide on platelet behavior].
    Verry M; Dechavanne M; Desnoyers P; Stoltz JF; Vainer H
    Nouv Presse Med; 1974 Oct; 3(33):2099-100. PubMed ID: 4471584
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hypoglycemic agents of the 2d generation].
    Giulietti M
    Clin Ter; 1978 Jul; 86(2):179-81. PubMed ID: 743858
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of gliclazide on prostaglandin I2 formation in normal and streptozotocin-induced diabetic animals.
    Fujitani B; Maeda J; Tsuboi T; Kadokawa T; Shimizu M
    Jpn J Pharmacol; 1983 Oct; 33(5):965-70. PubMed ID: 6358588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short- and long-term gliclazide effects on pancreatic islet cell function and hepatic insulin extraction in non-insulin-dependent diabetes mellitus.
    Wajchenberg BL; Santomauro AT; Giannella-Neto D; Borghi VC; Porrelli RN
    Diabetes Res Clin Pract; 1992 Aug; 17(2):89-97. PubMed ID: 1425152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of ingestion time of gliclazide in relationship to meals on plasma glucose, insulin and C-peptide levels.
    Batch J; Ma A; Bird D; Noble R; Charles B; Ravenscroft P; Cameron D
    Eur J Clin Pharmacol; 1990; 38(5):465-7. PubMed ID: 2199202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of diamicron on various blood coagulation indices in patients with type II diabetes mellitus].
    Balabolkin MI; Morozova TP; Zhizhina SA; Novikova NV; Nepsha VD
    Klin Med (Mosk); 1983 Apr; 61(4):66-8. PubMed ID: 6865293
    [No Abstract]   [Full Text] [Related]  

  • 15. Gliclazide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in diabetes mellitus.
    Holmes B; Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1984 Apr; 27(4):301-27. PubMed ID: 6373223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-platelet effects of long-term treatment with gliclazide in diabetic patients.
    Ponari O; Civardi E; Megha S; Pini M; Portioli D; Dettori AG
    Thromb Res; 1979; 16(1-2):191-203. PubMed ID: 116387
    [No Abstract]   [Full Text] [Related]  

  • 17. [Macroangiopathy and type 2 diabetes mellitus: significance of Diamicron].
    Lesobre B
    Journ Annu Diabetol Hotel Dieu; 1990; ():325-34. PubMed ID: 2195215
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of gliclazide on prostaglandin and thromboxane synthesis in guinea-pig platelets.
    Tsuboi T; Fujitani B; Maeda J; Yoshida K; Shimizu M
    Thromb Res; 1981 Jan 1-15; 21(1-2):103-10. PubMed ID: 7233394
    [No Abstract]   [Full Text] [Related]  

  • 19. A clinical study on insulin receptors of mononuclear cells in diabetes.
    Dalimunthe D
    Hiroshima J Med Sci; 1980 Dec; 29(4):203-18. PubMed ID: 7009506
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of insulin and gliclazide administration on insulin action and insulin binding in aged rat adipocytes].
    Iwamoto Y; Akanuma Y; Kosaka J
    Horumon To Rinsho; 1982 Nov; 30(11):1279-82. PubMed ID: 6761013
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.